Abbott launches HBsAg Next Assay for enhanced detection of Hepatitis B Assay to help detect HBV infections and mutants at an earlier stage even in vaccinated individuals
Why hunting, tracking, analysing and studying SARS-CoV-2 and other pathogens must continue Regardless of the pandemic moving into the endemic phase in certain regions, Mary Rodgers, principal research scientist at Abbott…
New research finds challenges in symptom recognition and diagnostic testing can impact patient… Forty per cent of physicians in India believe that a “lack of standardised approach for diagnosing CAD/PAD” is a top obstacle to…
US FDA authorises first COVID-19 antigen test where results can be read directly from testing card Cautions that negative results from antigen tests may need to be confirmed with a molecular test prior to making treatment…
Roger Low, Senior Manager Marketing – South Asia, Abbott Diagnostics, Singapore | Dx Summit 2019 Dx Summit 2019 | India's Largest Diagnostic Business Conclave | 22-23 February 2019 | Novotel Airport, Hyderabad
Unifying across the care continuum for measurable impact to patients, payors, clinicians and entire… Highlights The lab can improve its impact on patients and clinicians satisfaction It is not easy to deliver value in…